85.75
Kodiak Sciences Inc (KOD) 最新ニュース
Kodiak Sciences Inc. (KOD) stock price, news, quote and history - Yahoo Finance Singapore
Kodiak Sciences More Than Doubles on Eye Disease Trial Results - Barchart.com
Form 13D/A Kodiak Sciences Inc. For: 1 October By Investing.com - Investing.com South Africa
Form 13D/A Kodiak Sciences Inc. For: 1 October By Investing.com - Investing.com Nigeria
Form 13D/A Kodiak Sciences Inc. For: 1 October By Investing.com - Investing.com Canada
Kodiak Sciences(KOD.US) 10% Shareholder Buys US$156.99 Million in Common Stock - Moomoo
A stock acquisition changes beneficial ownership by more than 1% at Kodiak Sciences (KOD). - Stock Titan
Baker Bros. Advisors Reports Multiple Open-Market Buys of Kodiak Sciences Stock - Kalkine Media
In 30 transactions, Baker funds bought shares of Kodiak Sciences (KOD). - Stock Titan
Funds buy Kodiak Sciences (KOD) shares at average prices of about $79–$86. - Stock Titan
Form 4 Kodiak Sciences Inc For: 29 September By Investing.com - Investing.com Canada
Form 4 Kodiak Sciences Inc For: 29 September By Investing.com - Investing.com South Africa
Form 4 Kodiak Sciences Inc For: 29 September By Investing.com - Investing.com Nigeria
Options at $2.49 a share are among those Kodiak Sciences (KOD) CEO exercised. - Stock Titan
Diluted net income available to common stockholders of Kodiak Sciences, Inc. – HAN:K27 - TradingView
KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears - Zacks Investment Research
Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs? - Stocktwits
Kodiak Sciences Inc (NASDAQ: KOD) Share Price, KOD Stock News, KOD Share Price & Updates - Kalkine
Form 8K Kodiak Sciences Inc For: 28 September By Investing.com - Investing.com Canada
Form 8K Kodiak Sciences Inc For: 28 September By Investing.com - Investing.com India
Both treatments met a year-one vision goal in Kodiak Sciences (KOD)'s eye disease trial. - Stock Titan
Why Is Kodiak Sciences (NASDAQ:KOD) Suddenly a Must-Watch Healthcare Stocks Name? - Kalkine Media
Kodiak Sciences (Nasdaq:KOD)Stock Analysis - Simply Wall Street
Kodiak Stock Soars (Again) As Data Shows Long-Lasting Eye Meds Are The 'Real Deal' (KOD) - Seeking Alpha
Kodiak Sciences to report phase 3 trial results Monday By Investing.com - Investing.com South Africa
What DAYBREAK Trial Results Could Mean For Kodiak Sciences Stock - simplywall.st
Goldman Sachs initiates Kodiak Sciences stock coverage with neutral rating - Investing.com
The Zacks Analyst Blog Highlights Kodiak Sciences, Celldex Therapeutics, Rapport Therapeutics and Vaxcyte - Zacks Investment Research
Kodiak Sciences (KOD) Pulls Back After A Strong Year, Is The Valuation Still Too Rich? - simplywall.st
H.C. Wainwright reiterates Kodiak Sciences stock rating on trial outlook By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Kodiak Sciences stock rating on trial outlook - Investing.com India
After $435,870 sale, Gilead (NASDAQ: GILD) CFO still holds 164K shares - Stock Titan
3 Small-Cap Biotechs With Binary Catalysts on the Calendar - marketbeat.com
Kodiak Sciences (KOD) Races Toward Three Make-Or-Break Trial Verdicts - Yahoo Finance
Kodiak Sciences (KOD): Three Phase 3 Readouts In SightWill The Data See It Through? - RTTNews
Former Sight Sciences (NASDAQ: SGHT) officer lines up more share sales after a string of summer trades - Stock Titan
Kodiak Sciences Inc (KOD) Peer Comparison – Compare with Others - valueresearchonline.com
What Kodiak Sciences (KOD)'s Widening Net Losses and Lower H1 Loss Per Share Mean For Shareholders - simplywall.st
BetterLife Pharma Inc. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants - Yahoo Finance
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 4.1%Time to Sell? - MarketBeat
Kodiak Sciences enrolls first patients in phase 3 DME trial By Investing.com - Investing.com Nigeria
HC Wainwright Lowers Earnings Estimates for Kodiak Sciences - MarketBeat
GSA Capital Partners LLP Takes $1.07 Million Position in Kodiak Sciences Inc. $KOD - MarketBeat
KOD Reiterates by HC Wainwright & Co. -- Price Target Maintained at $58 - GuruFocus
H.C. Wainwright reiterates Kodiak Sciences stock rating at buy By Investing.com - Investing.com Nigeria
HC Wainwright Reaffirms "Buy" Rating for Kodiak Sciences (NASDAQ:KOD) - MarketBeat
H.C. Wainwright reiterates Kodiak Sciences stock rating at buy - Investing.com
H.C. Wainwright reiterates Kodiak Sciences stock rating at buy By Investing.com - Investing.com India
H.C. Wainwright reiterates Kodiak Sciences stock rating at buy By Investing.com - Investing.com UK
H.C. Wainwright reiterates Kodiak Sciences stock rating at buy - Investing.com
大文字化:
|
ボリューム (24 時間):